Education
Albany Law School, J.D., 2006
University of Florida, Ph.D., Molecular Genetics and Microbiology, 2004
University of New Hampshire, B.S., Microbiology, 1994

Professional Experience
Technical Specialist, Schmeiser, Olsen & Watts LLP, 2004 – 2006
Oral Presentation, International Herpesvirus Workshop, Regensberg, Germany, August 2001
Poster Presentation, International Herpesvirus Workshop, Boston, MA, August 1999
Laboratory Teaching Assistant, Arizona State University, 1996-1999
Laboratory Technician, Albany Medical College, 1995-1996

Concentration
Biotechnology Patent Prosecution

Admitted
United States Patent and Trademark Office, 2006
State Bar of Massachusetts, 2006
State Bar of New York, 2007

Representative Publications
“Deacetylation of the herpes simplex virus type 1 latency associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant”, Journal of Virology, (2006)

“Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model”, Journal of Virology, (2004)

“EHV-4 establishes a latent infection in equine trigeminal ganglia and lungs” (In preparation)

Representative Cases
Promega Corp. v. Life Technologies Corp., No. 10-cv-281 (W.D. Wis. Feb. 16, 2012) (jury award of $52 million to client Promega Corporation)